She lost both her parents tragically. Yet this Easton grad is studying to be a cancer researcher.
Updated Jan 10, 2021;
Posted Jan 09, 2021
A dryanna Jenkins of Easton won a scholarship to study immunology at the University of Cambridge. She lost both of her parents by the time she was 16.Courtesy Times Eye Photography
Facebook Share
A’dryanna Jenkins’ improbable path from South Side Easton to Marshall Scholar at the University of Cambridge seemed impossible just seven years ago.
She failed her freshman year at Easton Area High School and was sent to Easton Area Academy to get back on track.
The 21-year-old biomedical student frequently missed school because she was trying to meet the needs of her four siblings and her mother. Her father wasn’t available to help. He was murdered by his girlfriend in Bethlehem in 2007.
E-Mail
IMAGE: Decio Eizirik, MD, PhD, Scientific Director of the Indiana Biosciences Research Institute Diabetes Center. view more
Credit: Indiana Biosciences Research Institute
Indianapolis, Ind. - A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center s Scientific Director Decio L. Eizirik, MD, PhD, has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues. This study, Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis and rheumatoid arthritis, is featured in the Jan. 6, 2021, edition of
Science Advances. We must move away from the present immune-centric-only view of autoimmune diseases, explains Eizirik. Indeed, trying to understand these diseases focusing on the immune system only, and forgetting the target tissues, may be similar to attempting to fly a plane with only one wing.
The U.S. new cases 7-day rolling average is 15.5 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 4.0 %
HIGHER than the rolling average one week ago. U.S. deaths due to coronavirus are now 16.9 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 201,555
U.S. Coronavirus hospitalizations are at a record 124,686 (for the next 9 days this is the number to watch as new cases and deaths will not be accurately reported)
U.S. Coronavirus deaths are at a record 3,725
U.S. Coronavirus immunizations have been administered to 0.7% of the population
s review of the past year s top stories, we are republishing it, along with an update on COVID-19 s mental health impacts, reviewing subsequent developments in 2020.
It was contracting the COVID-19 coronavirus herself that made Maryland psychologist Myrna Frank, PhD, completely transition her practice to telehealth appointments.
On Monday, March 9, the day after Frank returned from the annual American Group Psychotherapy Association meeting in New York, she was seeing clients in her clinic, being careful to avoid touching surfaces and keeping her hands as clean as possible. But that night, the fever, chills, and nausea presented suddenly. I felt incapacitated for 36 hours, Frank told
Article content
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Neanderthal gene protects against COVID-19
We apologize, but this video has failed to load.
Try refreshing your browser, or Neanderthal gene protects against COVID-19: Study Back to video
A specific form of a protein passed down from Neanderthals protects against severe COVID-19, and medications that boost levels of this protein could potentially help treat the disease, according to a study reported on medRxiv on Thursday ahead of peer review. The protein, called OAS1, is involved in the body’s response to viruses. People with higher levels of the Neanderthal-related form of OAS1 are less susceptible to COVID-19, and if they do become infected, they are at lower risk for hospitalization, intubation and death, the researchers found. “This protective form of OAS1 is present in